Latest Autism therapies Stories

MELBOURNE, Fla., April 26, 2011 /PRNewswire/ -- The current prevalence of autism spectrum disorder is alarmingly high. Although there is no cure for autism, it is possible to manage and treat the comorbid medical conditions associated with autism. One of these conditions, sleeping disturbance, can be challenging to treat. A new study published in Developmental Medicine and Child Neurology by Dr. Daniel Rossignol (International Child Development Resource Center, Melbourne, FL) and Dr....

Teach children with over-responsive sensory modulation to successfully engage in activities within the home, school, and community. Framingham, MA (PRWEB) April 6, 2011 Therapro is now offering Sensory Stories Strategy Card Decks as a supplement to its already popular Sensory Stories range of products focused on autism therapy. Sensory Stories teach children with over-responsive sensory modulation and sensory integration disorder to successfully engage in activities within the home,...

ROCKVILLE, Md., April 4, 2011 /PRNewswire-USNewswire/ -- Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders (ASDs), but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS' Agency for Healthcare Research and Quality. The research results were published online in the journal Pediatrics. The comparative effectiveness report found that two commonly used medications...

RYE, N.Y., March 21, 2011 /PRNewswire/ -- Curemark, LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III clinical trials for CM-AT, its autism treatment. Curemark has reached its targeted enrollment for the study of a total 170 children, who are participating in the CM-AT Phase III trial at 18 sites across the country. "We have been extremely pleased...

PHOENIX, Nov. 12, 2010 /PRNewswire/ -- A landmark study proves that children are capable of recovery from autism, or of making substantial gains in cognitive and adaptive functioning, as well as language skills, according to results released last night by Dr. Doreen Granpeesheh, founder of the Center for Autism and Related Disorders, Inc. (CARD). (Photo: http://photos.prnewswire.com/prnh/20101112/LA00412) (Photo: http://www.newscom.com/cgi-bin/prnh/20101112/LA00412) The three-year study,...

People with autism spectrum disorders (ASD) are thought to have a specific profile of cognitive strengths and weaknesses"”difficulties appreciating others' thoughts and feelings, problems regulating and controlling their behavior, and an enhanced ability to perceive details"”but few studies have tracked children's cognitive skills over time. Now new longitudinal research provides clues that can inform our understanding of ASD."Parents and clinicians already know that the behavioral...

RYE, N.Y., Sept. 13 /PRNewswire/ -- Matthew F. Heil, Ph.D., senior vice president of research and development at Curemark LLC (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, recently attended the North American Bio Forum 2010 in Laval, Canada, at the invitation of the Canadian government/Laval Technopole, Curemark said. Held by the Laval Technopole International Business Centre and The Biotech City on September 1 and 2, the...

Antidepressants commonly prescribed to people with autistic spectrum disorders cannot be recommended based on current evidence, a new study by Cochrane Researchers concludes. Despite some evidence of benefits in adults diagnosed with autism, they say there is no evidence for any benefits associated with selective serotonin reuptake inhibitors (SSRIs) in children, who may suffer serious adverse effects as a result of taking the drugs.Autistic spectrum disorders are difficult to treat because...

Study shows 60 percent of children ages 11 and older take at least 1 medicationBehavioral interventions typically are the first line of treatment to manage unwanted behaviors in children with autism spectrum disorders (ASDs). If behaviors do not improve, medications frequently are added to the mix.Research conducted by Autism Speaks' Autism Treatment Network (ATN) shows that use of psychotropic medications is common among children with ASD, with 27 percent of those enrolled in the network...

The serious behavior problems that can occur in children with autism and related conditions can be reduced with a treatment plan that includes medication combined with a structured training program for parents, according to Yale University researchers and their colleagues.Published in the December 2009 issue of the Journal of the American Academy of Child and Adolescent Psychiatry, the study was conducted by the National Institute of Mental Health (NIMH) Research Units on Pediatric...